This survey is a collaborative effort by ICUDDR, NECPAM and ISAM. Together, we are trying to assess the impact recent reductions in funding have had to the workforce of fields dealing with substance use related issues.
CSUCH’s data visualisation tool can be used to estimate substance use trends across the country. The data helps inform programs, practices, and research to protect communities, save lives, and improve the well-being of people in Canada.
Spotlight: Top 3 causes of death due to substance use in Canada
More than 200 people died each day due to substance use (SU) in 2020 (the latest year for which data are available). That works out to 73,994 deaths that year. The average age of death due to SU was 45 years. Tobacco use caused 63% (46,366) of SU-related deaths, followed by alcohol at 23%...
Addiction and obesity share similar neurological pathways, both linked to compulsive behaviors and the brain's reward system. Research has highlighted the potential of GLP-1 receptor agonists, originally developed for diabetes, to help manage both appetite and addictive cravings. These medications, such as semaglutide, may regulate addictive behaviors by influencing reward circuits in the brain. However, they come with potential side effects, and their long-term effects are still under investigation.
In addition, a new compound, 5-Methoxy-2-aminoindane (MEAI), is being researched for its...
This week, we say goodbye to our dear friend and mentor, Jeff Lee, the founding Executive Director of ISSUP. Jeff was a steadfast advocate for the professionalization of prevention, insisting that those working in this field should be appropriately specialized. He often reminded us that while generalists and treatment specialists are well-meaning and deeply embedded within their communities, they are not always best placed to develop and implement evidence-based prevention systems. Jeff emphasized that prevention must be treated as a distinct science—one that is grounded in rigorous research...
L’équipe des chapitres nationaux a tenu une réunion virtuelle cruciale de 2 jours les 10 et 11 décembre 2024 pour évaluer le modèle opérationnel actuel des chapitres nationaux et identifier les opportunités d’amélioration et de croissance. La réunion a été surnommée « Réunion de vision » pour refléter l’ordre du jour principal : Élaborer un plan tourné vers l’avenir pour les chapitres nationaux de l’ISSUP.
The Global Recovery Network is committed to providing valuable and relevant content for our community.
To ensure our upcoming webinar series aligns with the needs and interests of our audience, we have developed this survey with U.S. based Faces and Voices of Recovery to determine which topics may be of most relevance. Our goal is to offer webinars that not only inform but also develop and build skills that support recovery, advocacy, and professional growth.
Your feedback is crucial in helping us design a webinar series that resonates with and benefits you.
Don't miss our latest newsletter for details of recent meetings and activities in Latin America and Africa. This issue also includes information on how to gain advanced clinical skills with the UTC16 Self Led Course.
On behalf of the Turkish Green Crescent Society, I would like to invite you to attend the 5th Youth Advocacy Forum on the theme "E-cigarettes and Vaping Products: An Overlooked Pandemic." The event will be held virtually via Zoom on August 21, 2024 from 2 to 5 pm (GMT+3). Established with the...
Learn about global drug trends from the authors of the World Drug Report 2024!
UNODC experts will present the World Drug Report 2024, giving an overview of the latest developments and diving into the most up-to-date global data. In the...
A global reference on drug markets, trends and policy developments, the World Drug Report offers a wealth of data and analysis and in 2024 comprises several elements tailored to different audiences.
European Monitoring Centre for Drugs and Drug Addiction and Europol (2024), EU Drug Market: Drivers and facilitators, https://www.emcdda.europa.eu/publications/eu-drug-markets/drivers-and-f…
EU Drug Market: Drivers and facilitators provides an overview of the key factors influencing the operation of the markets for illicit drugs in the European Union. It considers the changes and developments happening in the wider environment in which the illicit drug market is embedded (drivers), and the people or processes (facilitators) that make it easier to commit drug-related criminality or avoid detection. The focus of the report is on identifying key issues and presenting recommendations for action at EU and Member State level.
European Monitoring Centre for Drugs and Drug Addiction (2024), European Drug Report 2024: Trends and Developments, https://www.emcdda.europa.eu/publications/european-drug-report/2024_en
The European Drug Report 2024: Trends and Developments presents the EMCDDA’s latest analysis of the drug situation in Europe. Focusing on illicit drug use, related harms and drug supply, the report provides a comprehensive set of national data across these themes, as well as on specialist drug treatment and key harm reduction interventions.
The purpose of the report is to provide an overview and summary of the European drug situation up to the end of 2023.
Stimulants are a class of drugs that act on the central nervous system, increasing alertness, energy, and attention while elevating mood. They achieve these effects by enhancing the activity of neurotransmitters such as dopamine and norepinephrine in the brain.
Many stimulant-related hazards are linked to intensive, high-dose, or long-term usage. The mode of administration plays a significant moderating role; injecting stimulants and smoking crack cocaine or methamphetamine have been specifically associated with more problematic use behaviours. Even people who use stimulants sporadically or...